This contract award is for the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML to the Defense Logistics Agency (DLA). The contract, valued at $3,506.79, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov). The contract has a ceiling value of $3,506.79 and is a Firm Fixed Price Delivery Order with a final completion date of January 31, 2025. The contract is not...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $1,887.80 and a completion date of February 3, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $2,036.86 for the supply of NALBUPHINE 100 MG/10 ML VIAL 10ML. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 18, 2025, with a completion date of February 19, 2025. This contract represents a small portion of Amerisourcebergen's broader contracting relationship with the federal government, as the company...
The federal contract award is for the delivery of Nalbuphine 100 mg/10 ml vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,473.54 and an ultimate completion date of December 29, 2023. This award is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
This federal contract award, valued at $1,366.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML medical supplies, with a performance period ending on December 15, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of 4565914311 - NALBUPHINE 10ML 25S, a pharmaceutical product. The contract has a ceiling value of $1,556.06 and a completion date of October 22, 2024. It is structured as a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA to provide a...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office division, involves the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML pharmaceutical products. The award, valued at $4,561.80, was made by the Defense Logistics Agency (DLA) on August 14, 2024, with a completion date of August 15, 2024. This is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for NALBUPHINE 200 MG/10 ML VIAL 10ML, a pain management medication. The total ceiling value is $4,266.65, with a firm fixed price pricing type. The ultimate completion date is June 24, 2024. This contract is not associated with a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,248.06 firm fixed-price contract is for the supply of the prescription medication nalbuphine hydrochloride in 10 mL vials. The contract has a completion date of September 18, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999 and...
This federal contract award, valued at $4,047.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...